In a report published Tuesday, Bank of America analyst Nikolay Beliov reiterated a Buy rating on Five9 FIVN, but lowered the price target from $10.00 to $8.50.
In the report, Bank of America noted, “The stock is down -24% in the after-market after FIVN reported in-line 2Q results and lowered 2014 revenue guidance by 4% ($4mn) at the second earnings call as a public company. This development is clearly disappointing but we believe market fundamentals are positive while the company's technology and product functionality is improving. The $4m impact ($2m per quarter) is split 70% in usage and 30% in seats.
"Six large customers (three healthcare and three business process outsourcers), which remain FIVN customers, scaled back as the Affordable Healthcare Act impacted spending plans. We estimate 1,000+ seats were impacted or ~3% of the install base. FIVN increased net income guidance slightly as it slowed down hiring of non-customer facing personnel. 2Q revenues, gross margins, and EPS came largely in-line. We lower our revenues by $2m/quarter, in-line with the slower spending for 2014 per quarter by these six customers. In light of the market potential, we view the current growth vs margin trade-off as the right strategy.”
Five9 closed on Monday at $7.62.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in